DICLOFENAC Actavis diclofenac sodium 50mg enteric-coated tablet blister pack

Country: Awstralja

Lingwa: Ingliż

Sors: Department of Health (Therapeutic Goods Administration)

Ingredjent attiv:

diclofenac sodium, Quantity: 50 mg

Disponibbli minn:

Medis Pharma Pty Ltd

INN (Isem Internazzjonali):

Diclofenac sodium

Għamla farmaċewtika:

Tablet, enteric coated

Kompożizzjoni:

Excipient Ingredients: lactose monohydrate; calcium hydrogen phosphate dihydrate; microcrystalline cellulose; maize starch; sodium starch glycollate; magnesium stearate; colloidal anhydrous silica; methacrylic acid copolymer; triethyl citrate; purified talc; titanium dioxide; iron oxide yellow

Rotta amministrattiva:

Oral

Unitajiet fil-pakkett:

50 tablets

Tip ta 'preskrizzjoni:

(S4) Prescription Only Medicine

Indikazzjonijiet terapewtiċi:

Inflammatory and degenerative forms of rheumatism; rheumatoid arthritis; osteoarthritis. Relief of acute or chronic pain states in which there is an inflammatory component. Symptomatic treatment of primary dysmenorrhoea.

Sommarju tal-prodott:

Visual Identification: Brown yellow enteric-coated tablet, biconvex with facet on both sides, intact surface and uniform colour.; Container Type: Blister Pack; Container Material: PVC/Al; Container Life Time: 18 Months; Container Temperature: Store below 25 degrees Celsius

L-istatus ta 'awtorizzazzjoni:

Licence status A

Data ta 'l-awtorizzazzjoni:

2012-08-14